We hypothesized that SDF-1 can decrease expression of the NLRP3 inflammasome and related proteins in synoviocytes from OA joints exhibiting synovitis and may have potential as a novel therapeutic target for synovitis in OA. Here, CXCL12 is linked to synovitis.